Hear insights from experts: Dr Aline Chaves, Prof. Makoto Tahara and Dr Ranee Mehra explore the rationale and latest data for immunotherapybased and targeted treatments in development for recurrent/metastatic SCCHN.

Watch now: https://touchoncologyime.org/futuret...

This activity is funded by an independent medical education grant from Seagen Inc. and Genmab US, Inc., and is jointly provided by USF Health and touchIME.